Scripps Research
@scrippsresearch
Scripps Research is one of the world's largest, private, non-profit biomedical research organizations. We are Science Changing Life.
At the Scripps Research Translational Institute, founder and director Eric Topol (@EricTopol) is using AI to reshape medicine, making it more accurate and personalized. Topol, who is also a cardiologist, executive vice president and the Gary and Mary West Chair of Innovative…
What can you expect to learn at #IBDCuttingEdge2025? Clinical trials, emerging therapies, surgical strategies, and patient-centered models—all designed to improve outcomes in IBD care & advance future therapies. Join us on: 📅 Sept 19–21 📍 Coronado, CA 🎟️ Register now:…

We can predict a person's risk of coronary artery disease better than ever before. Cover of new @NatureMedicine regarding our @ScrippsRTI @scrippsresearch recent paper @ATorkamani nature.com/articles/s4159…
Where did RNA come from? Origin-of-life scientists from the lab of Ramanarayanan Krishnamurthy show how ribose may have become the sugar of choice for RNA development. In their new study, the team found that ribose binds to phosphate—another molecular component of RNA—more…

Behind every cure is someone who believed in the power of science. Philanthropy is essential to Scripps Research, accelerating discoveries that changes lives. Your gift helps our scientists turn bold research into real hope in cancer, brain disease and other urgent health…

Neuroscientists have long questioned how the brain interprets complex sensations like touch or pain. Scripps Research is determined to provide answers. Spearheaded by a team of experts led by professor and Nobel laureate Ardem Patapoutian, the institute is transforming our…

Today’s the day! Join us at 1PM PT for the second installment of our virtual masterclass summer series. To join this session or learn more about the Biotech Innovation Summit, contact [email protected]
Timing is everything—especially in early-stage pharma. Join us on July 17 for the second installment of our virtual masterclass summer series where founders and pharma partners share what real early engagement looks like. ✅ Proven outreach strategies 🗣️ Candid, firsthand…
#ICYMI: Last week, @nbcsandiego and @sdut showcased the first-ever trial of "switchable" CAR-T therapy for breast cancer, led by scientists at Scripps Research and the Calibr-Skaggs Institute for Innovative Medicines. Travis Young, PhD (@CARTCellTherapy), Vice President of…
A new microchip invented by @WardLab1 can reveal how a person’s antibodies interact with viruses—using just a drop of blood, offering researchers faster and clearer insights that could help accelerate vaccine development and antibody discovery, as shown in @natBME. The new…

Viome Life Sciences (@MyViome) and Scripps Research announced a strategic partnership to develop and clinically validate the first at-home RNA test designed to detect precancerous colon polyps, enabling early prevention of colorectal cancer. This strategic partnership comes amid…

Timing is everything—especially in early-stage pharma. Join us on July 17 for the second installment of our virtual masterclass summer series where founders and pharma partners share what real early engagement looks like. ✅ Proven outreach strategies 🗣️ Candid, firsthand…

As humans age, the body’s ability to repair and replace tissue declines, resulting in illness and infirmity. This begs the question: How can science and medicine help people around the globe stay healthy as they live longer? To address this pressing need, scientists from the…

Roughly 100,000 people die each year from venomous snakebites. To change that, Irene Khalek, PhD, a staff scientist in the Jardine lab at Scripps Research, is designing a universal antivenom that could protect against all medically relevant snakebites. ow.ly/r1CN50WkCXH

At Science in Action, a new Front Row post-lecture activity, Lairson’s lab showed attendees how they apply cellular and molecular techniques to drive myelin repair, from guiding stem cell differentiation to modeling neural signaling. See the full talk: frontrow.scripps.edu
What if the future of medicine prioritized access over profit? Calibr-Skaggs scientists are advancing single-dose treatments and chemical vaccines to address health challenges long overlooked by industry. Read the full feature: ow.ly/jiNh50Wiyxy
Congrats to Donna Blackmond, recipient of the 2025 Centenary Prize for Chemistry and Communication from @RoySocChem—awarded for pioneering work in kinetic methods of organic catalysis, asymmetric catalysis mechanisms, homochirality, and excellence in communication.…

Prof. Jin-Quan Yu (@YulabJin) will receive the 5th Akira Suzuki Award for his research on C–H bond activation, which makes it easier to build complex molecules. His work accelerates advances in pharmaceuticals, molecular tools and materials science. More: ow.ly/z0BL50WhOQf
This year on #SCL, we’ve had some amazing scientists join us to share their work, their stories and what drives them. There’s one question we love to ask our guests: What advice would you give to scientists just starting out?Hear what they had to say: ow.ly/5l2s50WagBV
In a study published in @ScienceTM, Scripps Research scientists show that pairing two vaccine adjuvants elicits a stronger, longer-lasting immune response against HIV in a preclinical model. More: ow.ly/m11p50WbXcS
